| IPO Company Profile © ipodata.com |
| Message Board | Quote | Chart | News | SEC Filings | Peer IPO Companies | Company's Home Page |
| Therasense, Inc. |
| 1360 South Loop Road, Alameda, CA 94502 * (510) 749-5400 |
| Business Description | The company develops and sells easy glucose self-monitoring systems that dramatically reduce the pain of testing for people with diabetes. |
| Offering Information Company has | |||
| Trading As | THER (NASNTL) | Industry | Manufacturing (SIC 3841) |
| Type of Stock Offered | Common Shares | Filing Date | 7/3/2001 |
| Domestic Shares Offered | 6,000,000 | Offer Date | 10/12/2001 |
| Foreign Shares Offered | 0 | Filing Range | $18.00 - $20.00 |
| Company Shares | 6,000,000 | Offer Price | $19.00 |
| Selling Shrhldrs Shares | 0 | Gross Spread | $1.330 |
| Gross Proceeds | $114,000,000 | Selling | $0.800 |
| Expenses | - - | Reallowance | $0.100 |
| Post-IPO Shares | 38,089,847 | Employees | - - |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| U.S. Bancorp Piper Jaffray | Lead Manager | (612) 342-6220 |
| SG Cowen | Co-manager | (212) 495-6000 |
| Thomas Weisel Partners LLC | Co-manager | (415) 364-2500 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | 6 Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/1998 | 12/31/1999 | 12/31/2000 | 6/30/2000 | 6/30/2001 | ||
| Revenues | - | - | 0.060 | 0.085 | 5.503 | 0.511 | 25.524 |
| Income from Oper. | - | - | -4.806 | -13.144 | -43.924 | -15.413 | -27.319 |
| Net Income | - | - | -4.664 | -13.058 | -43.592 | -15.059 | -26.933 |
| E.P.S | - | - | - | - | - | - | - |
| Revenue Growth (%) | - | - | 41.67 | 6,374.118 | 4,894.91 | ||
| Net Income Growth (%) | - | - | - | - | - | ||
| Oper. Profit Margin (%) | - | - | - | - | - | - | - |
| Net Profit Margin (%) | - | - | - | - | - | - | - |
| Cash Flow - Oper. | -36.78 | -17.03 | -19.41 | ||||
| Cash Flow - Inv. | 0.58 | 0.24 | -854.51 | ||||
| Cash Flow - Fin. | 46.41 | 44.09 | 52.88 | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 6/30/2001 | Financial Ratios | ||||
| Total Assets | 78.98 | Current Assets | 71.42 | Current Ratio | 1.95 |
| Total Liab. | 44.06 | Current Liab. | 36.61 | Debt Ratio | 55.78% |
| Total Equity | 34.93 | Working Cap. | 34.81 | Debt to Equity Ratio | 1.26 |
| Cash | 45.15 | Return on Assets | - | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used for additional sales and marketing efforts and research and development as well as for working capital and other general corporate purposes. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Wilson, Sonsini, Goodrich & Rosati |
| Bank's Law Firm | Brobeck, Phleger & Harrison |
| Registrar/Transfer Agent | Computershare Invstor Services LLC |
| Auditor | Pricewaterhouse Coopers LLC |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |
| Principal Shareholders | ||
| Name of Shareholder | % Owned Before | % Owned After |
| InterWest Partners | 15.11 | |
| Brentwood Venture Capital | 11.35 | |
| Delphi Ventures | 10.29 | |
| E. Heller & Co | 9.75 | |
| Sequoia Capital | 7.42 | |
| Disetronic Holding AG | 7.33 | |
| Lehman Brothers | 7.15 | |
| MedVentures Associates | 5.60 | |
| Note: represents ownership of 5% or more prior to the offering. | ||